Yvonne Briggs
Investor Relations, Alliance Advisors
Replay available
Opko Health, Inc. (OPK) Q4 2025 Earnings Call
Opko Health, Inc. (NASDAQ: OPK) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Philip Frost
Chairman and Chief Executive Officer
Dr. Elias Zerhouni
Vice Chairman and President
Adam Logel
Chief Financial Officer
Brian Chang
Analyst, J.P. Morgan Securities
Gary Nabal
Head of Collaboration with Merck
Yael Chen
Analyst, Leadlaw & Toh
Edward Tenthoff
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Opko Health, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.216 Hello and welcome to the Opco Health fourth quarter 2025 financial 00:00:05.216 -- 00:00:10.061 results conference call. All participants will be in listen-only mode. 00:00:10.061 -- 00:00:14.326 Should you need assistance, please signal a conference specialist by pressing the star 00:00:14.326 -- 00:00:19.311 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:19.311 -- 00:00:25.097 questions. To ask your question, you may press star then one on your telephone keypad. 00:00:25.097 -- 00:00:28.634 To withdraw your question, please press star then two. 00:00:28.634 -- 00:00:33.240 Please note this event is being recorded. I would now like to turn the conference over 00:00:33.240 -- 00:00:37.045 to Yvonne Briggs. Please go ahead. 00:00:37.045 -- 00:00:42.231 Thank you, Operator. Good afternoon. This is Yvonne Briggs with Alliance Advisors IR. 00:00:42.231 -- 00:00:46.637 Thank you all for joining today's call to discuss Opco Health financial results for the 00:00:46.637 -- 00:00:49.320 fourth quarter of 2025. I'd 00:00:49.320 -- 00:00:53.585 like to remind you that any statements made during this call by management, other than 00:00:53.585 -- 00:00:58.612 statements of historical fact, will be considered forward-looking and, as such, are subject 00:00:58.612 -- 00:01:03.519 to risks and uncertainties that could materially affect the company's results. 00:01:03.519 -- 00:01:07.964 Those forward-looking statements include, without limitation, the various risks described 00:01:07.964 -- 00:01:12.971 in the company's SEC filings, including the annual report on Form 10-K for the 00:01:12.971 -- 00:01:16.195 year ended December 31, 2025 that 00:01:16.195 -- 00:01:18.639 was just filed earlier today. ...